1. Home
  2. IMAB vs INTT Comparison

IMAB vs INTT Comparison

Compare IMAB & INTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMAB
  • INTT
  • Stock Information
  • Founded
  • IMAB 2014
  • INTT 1981
  • Country
  • IMAB United States
  • INTT United States
  • Employees
  • IMAB N/A
  • INTT N/A
  • Industry
  • IMAB Biotechnology: Pharmaceutical Preparations
  • INTT Semiconductors
  • Sector
  • IMAB Health Care
  • INTT Technology
  • Exchange
  • IMAB Nasdaq
  • INTT Nasdaq
  • Market Cap
  • IMAB 79.9M
  • INTT 91.4M
  • IPO Year
  • IMAB 2020
  • INTT 1997
  • Fundamental
  • Price
  • IMAB $0.95
  • INTT $8.27
  • Analyst Decision
  • IMAB Strong Buy
  • INTT Strong Buy
  • Analyst Count
  • IMAB 3
  • INTT 2
  • Target Price
  • IMAB $8.00
  • INTT $16.00
  • AVG Volume (30 Days)
  • IMAB 289.3K
  • INTT 30.9K
  • Earning Date
  • IMAB 03-13-2025
  • INTT 03-26-2025
  • Dividend Yield
  • IMAB N/A
  • INTT N/A
  • EPS Growth
  • IMAB N/A
  • INTT N/A
  • EPS
  • IMAB N/A
  • INTT 0.22
  • Revenue
  • IMAB $3,313,984.00
  • INTT $121,971,000.00
  • Revenue This Year
  • IMAB N/A
  • INTT $7.31
  • Revenue Next Year
  • IMAB N/A
  • INTT $5.77
  • P/E Ratio
  • IMAB N/A
  • INTT $36.28
  • Revenue Growth
  • IMAB N/A
  • INTT N/A
  • 52 Week Low
  • IMAB $0.84
  • INTT $6.28
  • 52 Week High
  • IMAB $2.00
  • INTT $14.35
  • Technical
  • Relative Strength Index (RSI)
  • IMAB 43.17
  • INTT 45.61
  • Support Level
  • IMAB $0.95
  • INTT $7.65
  • Resistance Level
  • IMAB $1.04
  • INTT $9.30
  • Average True Range (ATR)
  • IMAB 0.06
  • INTT 0.43
  • MACD
  • IMAB -0.01
  • INTT -0.14
  • Stochastic Oscillator
  • IMAB 10.53
  • INTT 33.70

About IMAB I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

About INTT inTest Corporation

inTest Corp is a supplier of test and process solutions for use in manufacturing and testing across a range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. The company manages its business as three operating segments which is also their reporting units that includes Electronic Test, Environmental Technologies and Process Technologies. Electronic Test (which includes semiconductor test equipment, flying probe and in-circuit testers), Environmental Technologies (which includes its thermal test, process and storage products) and Process Technologies (which includes induction heating and video imaging products). They operate their business worldwide and sells its products both domestically and internationally.

Share on Social Networks: